Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
Masatoshi WakuiYuta FujimoriShoko NakamuraYoshino KondoYuko KurodaShusaku OkaTerumichi NakagawaHisako KatagiriMitsuru MurataPublished in: Journal of clinical pathology (2019)
The results provide insights into anticoagulation with bivalent DTIs.